No Data
No Data
Special treat Asahi Blue (000040.SZ) has been applied for reorganization and pre-reorganization by creditors, as well as a risk warning for fund occupation and delisting.
ST Xulan (000040.SZ) announced that the bondholders of the company have found that the company is unable to repay the matured debt and clearly lacks the ability to repay...
September 11th A-shares Lightning Rod | Henan Jindan Lactic Acid Technology: Guangzhou Chengxin, a shareholder, plans to reduce its shareholding by no more than 2.99%; ST Xulan: Stock trading may be subject to delisting risk warning.
Henan Jindan Lactic Acid Technology's shareholder, Guangzhou Chengxin, plans to reduce its shareholding by no more than 2.99%; Anfu Ce Link Limited's specific shareholders, Da Sheng Investment and He Sheng Investment, plan to jointly reduce their shareholding by no more than 1.65 million shares; Weide Information terminates the planning of major asset restructuring; Improve Medical Instruments' affiliated subsidiaries' business does not include human stem cell, gene diagnosis and treatment technology development and application; The special treat Xulan's stocks may be subject to delisting risk warning.
ST Asahi Blue: 2024 Semi-Annual Report Summary
ST Asahi Blue: 2024 Semi-Annual Report
ST Xulan (000040.SZ): A net loss of 92.8661 million yuan in the first half of the year, a year-on-year turnaround from profit to loss.
ST Xulan (000040.SZ) announced its semi-annual report for 2024, with a total operating revenue of 541 million yuan, a year-on-year decrease of 53.21%; a net income attributable to shareholders of the listed company of -92.8661 million yuan, a year-on-year change from profit to loss; a net income attributable to shareholders of the listed company after deducting non-recurring gains and losses of -89.9381 million yuan, a year-on-year change from profit to loss; basic earnings per share of -0.0625 yuan.
ST Xulan (000040.SZ) released its performance for the first half of the year, with a loss of 92.8661 million yuan compared to a profit.
ST Xulan (000040.SZ) released its 2024 interim report, with revenue of 0.541 billion...
No Data
No Data